Mamaearth expands its healthcare and wellness presence with a 58% stake in Fluence Pharma.
Beauty and personal care major Honasa Consumer has officially called off its proposed acquisition of a 58% stake in Fluence Pharma for ₹135 crore. 1
The parent company behind prominent beauty brands such as Mamaearth decided to terminate the strategic transaction, halting the planned majority buyout that was initially valued at ₹135 crore for the 58% stake in the pharmaceutical company.
Strategic corporate acquisitions in the direct-to-consumer and beauty and personal care sectors have faced dynamic shifts as major players continuously reevaluate their expansion strategies and portfolio consolidation efforts.
The termination of the Fluence Pharma deal means Honasa Consumer will redirect its corporate focus and capital resources toward organic growth initiatives and its existing portfolio of personal care brands.
Market observers note that corporate deal-making in India’s fast-moving consumer goods landscape requires careful alignment of long-term strategic goals, prompting firms to walk away from transactions when conditions shift.